Precede

Developer of liquid biopsy platform providing disease-defining biology from blood tests

placeBoston, Massachusetts, United States calendar_todayFounded 2021 language precede.bio

Social engagement

Social engagement: 6.6K social following, 8 posts in the last 12 months — below the industry typical range.

Investor mix

8 investors on record; lead investors include 5AM Ventures, Dana Farber, Lilly Asia Ventures, Stealth.

Investor typeCountShare
Venture capital338%
Private equity113%
Other / undisclosed450%

Recent activity

29 Jun 2026
Recognition
26 May 2026
Event
ASCO26 data presentations with collaborators at AstraZeneca and Merck Healthcare
21 Apr 2026
Product launch
Precede Bio InsightTM
Coming soon